We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Results 1 to 5 of 9



Intellectual Property - 2015 Year in Review

Australia - December 22 2015 AstraZeneca has lost patent protection for its blockbuster cholesterol-lowering drug Crestor (rosuvastatin). In AstraZeneca AB v Apotex Pty Ltd…

Co-authors: Monique Nicolle.


Commonwealth given green light to recover millions in compensation

Australia - December 22 2015 The Commonwealth of Australia is one step closer in its efforts to seek to recover over A$60 million in compensation from originators, Sanofi and…

Co-authors: Monique Nicolle.


TPP agreed - data exclusivity for biologics issue resolved

Australia - October 7 2015 Data exclusivity is an administrative restriction on regulatory agencies from using regulatory dossiers relating to registered therapeutic products…

Co-authors: Toby Patten, Anne Petterd, Ben McLaughlin.


Trans-Pacific Partnership (TPP) and data exclusivity for biologics

Asia-Pacific, Australia, USA - August 19 2015 We understand that one of the three key outstanding issues in Trans-Pacific Partnership (TPP) negotiations is the period of data exclusivity which…

Co-authors: Toby Patten, Anne Petterd, Ben McLaughlin.


Intellectual property - 9 July 2015

Australia - July 9 2015 The High Court is expected to deliver its much anticipated decision in D'Arcy v Myriad Genetics later this year determining whether isolated nucleic…

Co-authors: Monique Nicolle.

Next »